ETHICAL APPROVAL STATEMENT
Cancer
CANCER
The study was approved by the Yale Human Investigation and the Connecticut Department of Public Health Committees, Geisinger Health Systems IRB, Dana‐Farber/Harvard Cancer Center Institutional Review Board (IRB), and all 21 Connecticut hospital IRBs. All participants gave written informed consent.